Redcare Pharmacy Forecast, price target & analysts
Redcare Pharmacy Target price 2025 - Analyst rating & recommendation
Redcare Pharmacy Classifications & Recommendation:
Redcare Pharmacy Price Target
| Target Price | €168.27 |
| Price | €114.80 |
| Potential |
46.58%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Redcare Pharmacy 2026 .
The average Redcare Pharmacy target price is €168.27.
This is
46.58%
register free of charge
€214.00
86.41%
register free of charge
€94.00
18.12%
register free of charge
|
|
| A rating was issued by 11 analysts: 9 Analysts recommend Redcare Pharmacy to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Redcare Pharmacy stock has an average upside potential 2026 of
46.58%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion € | 2.37 | 2.99 |
| 31.79% | 26.07% | |
| EBITDA Margin | 1.26% | 2.14% |
| 54.51% | 70.35% | |
| Net Margin | -1.92% | -0.75% |
| 186.50% | 60.89% |
11 Analysts have issued a sales forecast Redcare Pharmacy 2025 . The average Redcare Pharmacy sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an Redcare Pharmacy EBITDA forecast 2025. The average Redcare Pharmacy EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Redcare Pharmacy Analysts have issued a net profit forecast 2025. The average Redcare Pharmacy net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | -2.27 | -1.12 |
| 260.32% | 50.66% | |
| P/E | negative | |
| EV/Sales | 0.81 |
9 Analysts have issued a Redcare Pharmacy forecast for earnings per share. The average Redcare Pharmacy EPS is
This results in the following potential growth metrics and future valuations:
Redcare Pharmacy...
Current Redcare Pharmacy Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Apr 06 2025 |
| WARBURG RESEARCH GMBH |
Locked
➜
Locked
|
Locked | Apr 03 2025 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Apr 03 2025 |
| METZLER EQUITIES |
Locked
➜
Locked
|
Locked | Apr 03 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| HSBC |
Locked
➜
Locked
|
Locked | Mar 23 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Apr 06 2025 |
|
Locked
WARBURG RESEARCH GMBH:
Locked
➜
Locked
|
Apr 03 2025 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Apr 03 2025 |
|
Locked
METZLER EQUITIES:
Locked
➜
Locked
|
Apr 03 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Apr 02 2025 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
HSBC:
Locked
➜
Locked
|
Mar 23 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
